Co-Authors
This is a "connection" page, showing publications co-authored by Olivier Sanchez and Benjamin Planquette.
Connection Strength
2.043
-
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. Thromb Res. 2021 01; 197:94-99.
Score: 0.228
-
Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J. 2018 12 14; 39(47):4196-4204.
Score: 0.200
-
Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment. Eur Respir J. 2018 11; 52(5).
Score: 0.199
-
Determinants and prognostic implication of diagnostic delay in patients with a first episode of pulmonary embolism. Thromb Res. 2018 11; 171:190-198.
Score: 0.196
-
Impact of previous head and neck cancer on postoperative complications after surgical resection for lung cancer: a case-control study. J Thorac Dis. 2018 Jul; 10(7):3948-3956.
Score: 0.194
-
Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism. Eur Respir J. 2017 Dec; 50(6).
Score: 0.187
-
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
Score: 0.061
-
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission. Eur Respir J. 2021 Jul; 58(1).
Score: 0.060
-
Intramuscular Vaccination in Adults with Therapeutic Anticoagulation in the Era of COVID-19 Vaccines Outbreak: A Practical Review. TH Open. 2021 Apr; 5(2):e166-e170.
Score: 0.059
-
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
Score: 0.059
-
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
Score: 0.059
-
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study. Arch Cardiovasc Dis. 2021 May; 114(5):381-393.
Score: 0.058
-
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. J Am Heart Assoc. 2021 04 20; 10(8):e018624.
Score: 0.058
-
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
Score: 0.058
-
Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells. Stem Cell Rev Rep. 2021 04; 17(2):639-651.
Score: 0.057
-
Predictive Factor for COVID-19 Worsening: Insights for High-Sensitivity Troponin and D-Dimer and Correlation With Right Ventricular Afterload. Front Med (Lausanne). 2020; 7:586307.
Score: 0.057
-
Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
Score: 0.056
-
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
Score: 0.055
-
Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2019 03 14; 40(11):902-910.
Score: 0.051
-
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial. Eur Respir J. 2018 01; 51(1).
Score: 0.047
-
Co-injection of mesenchymal stem cells with endothelial progenitor cells accelerates muscle recovery in hind limb ischemia through an endoglin-dependent mechanism. Thromb Haemost. 2017 10 05; 117(10):1908-1918.
Score: 0.045